ENO1 and Cancer

被引:115
作者
Huang, Chen Kai [1 ]
Sun, Ying [2 ]
Lv, Lei [3 ]
Ping, Yong [4 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cellular Biol, 110 Sproul Hall, Berkeley, CA 94720 USA
[2] Shanghai Jiao Tong Univ, Dept Immunol & Microbiol, Sch Med, South Chongqing Rd 225, Shanghai, Peoples R China
[3] Fudan Univ, MOE Key Lab Metab & Mol Med, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai 200032, Peoples R China
[4] Shanghai Jiao Tong Univ, Minist Educ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200240, Peoples R China
关键词
ANTI-ALPHA-ENOLASE; LUNG-CANCER; PROTEOMIC ANALYSIS; DOWN-REGULATION; T-CELLS; EXPRESSION; GLYCOLYSIS; IDENTIFICATION; CARCINOMA; AUTOANTIBODIES;
D O I
10.1016/j.omto.2021.12.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
alpha-Enolase (ENO1), also known as 2-phospho-D-glycerate hydrolase, is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglyceric acid to phosphoenolpyruvic acid during glycolysis. It is a multifunctional oncoprotein that is present both in cell surface and cytoplasm, contributing to hit seven out of ten "hallmarks of cancer." ENO1's glycolytic function deregulates cellular energetic, sustains tumor proliferation, and inhibits cancer cell apoptosis. Moreover, ENO1 evades growth suppressors and helps tumors to avoid immune destruction. Besides, ENO1 "moonlights" on the cell surface and acts as a plasminogen receptor, promoting cancer invasion and metastasis by inducing angiogenesis. Overexpression of ENO1 on a myriad of cancer types together with its localization on the tumor surface makes it a great prognostic and diagnostic cancer biomarker as well as an accessible oncotherapeutic target. This review summarizes the up-to-date knowledge about the relationship between ENO1 and cancer, examines ENO1's potential as a cancer biomarker, and discusses ENO1's role in novel onco-immunotherapeutic strategies.
引用
收藏
页码:288 / 298
页数:11
相关论文
共 90 条
[1]   Alpha-Enolase: Emerging Tumor-Associated Antigen, Cancer Biomarker, and Oncotherapeutic Target [J].
Almaguel, Frankis A. ;
Sanchez, Tino W. ;
Ortiz-Hernandez, Greisha L. ;
Casiano, Carlos A. .
FRONTIERS IN GENETICS, 2021, 11
[2]   Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes [J].
Altenberg, B ;
Greulich, KO .
GENOMICS, 2004, 84 (06) :1014-1020
[3]   The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells [J].
Bergmann, Simone ;
Schoenen, Hanne ;
Hammerschmidt, Sven .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 (08) :452-462
[4]   Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors [J].
Cancemi, Patrizia ;
Buttacavoli, Miriam ;
Roz, Elena ;
Feo, Salvatore .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (16)
[5]   Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest [J].
Capello, Michela ;
Ferri-Borgogno, Sammy ;
Riganti, Chiara ;
Chattaragada, Michelle Samuel ;
Principe, Moitza ;
Roux, Cecilia ;
Zhou, Weidong ;
Petricoin, Emanuel F. ;
Cappello, Paola ;
Novelli, Francesco .
ONCOTARGET, 2016, 7 (05) :5598-5612
[6]   α-enolase: a promising therapeutic and diagnostic tumor target [J].
Capello, Michela ;
Ferri-Borgogno, Sammy ;
Cappello, Paola ;
Novelli, Francesco .
FEBS JOURNAL, 2011, 278 (07) :1064-1074
[7]   Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners [J].
Cappello, Paola ;
Curcio, Claudia ;
Mandili, Giorgia ;
Roux, Cecilia ;
Bulfamante, Sara ;
Novelli, Francesco .
CANCERS, 2018, 10 (02)
[8]   Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer [J].
Cappello, Paola ;
Rolla, Simona ;
Chiarle, Roberto ;
Principe, Moitza ;
Cavallo, Federica ;
Perconti, Giovanni ;
Feo, Salvatore ;
Giovarelli, Mirella ;
Novelli, Francesco .
GASTROENTEROLOGY, 2013, 144 (05) :1098-1106
[9]   Three are better than one: Plasminogen receptors as cancer theranostic targets [J].
Ceruti P. ;
Principe M. ;
Capello M. ;
Cappello P. ;
Novelli F. .
Experimental Hematology & Oncology, 2 (1)
[10]   Identification of α-enolase as an autoantigen in lung cancer:: Its overexpression is associated with clinical outcomes [J].
Chang, Gee-Chen ;
Liu, Ko-Jiunn ;
Hsieh, Chia-Ling ;
Hu, Tsai-Shu ;
Charoenfuprasert, Suparat ;
Liu, Hsiung-Kun ;
Luh, Kwen-Tay ;
Hsu, Li-Han ;
Wu, Chew-Wen ;
Ting, Chou-Chik ;
Chen, Chih-Yi ;
Chen, Kun-Chieh ;
Yang, Tsung-Ying ;
Chou, Teh-Ying ;
Wang, Wen-Hua ;
Whang-Peng, Jacqueline ;
Shih, Neng-Yao .
CLINICAL CANCER RESEARCH, 2006, 12 (19) :5746-5754